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Enzymes at the phosphoenolpyruvate (PEP)–pyruvate–
oxaloacetate or anaplerotic (ANA) node control the metabolic
flux to glycolysis, gluconeogenesis, and anaplerosis. Here we
used genetic, biochemical, and 13C isotopomer analysis to char-
acterize the role of the enzymes at theANAnode in intracellular
survival of the world’s most successful bacterial pathogen,
Mycobacterium tuberculosis (Mtb). We show that each of the
four ANA enzymes, pyruvate carboxylase (PCA), PEP carboxy-
kinase (PCK), malic enzyme (MEZ), and pyruvate phosphate diki-
nase (PPDK), performs a unique and essential metabolic function
during the intracellular survival ofMtb.We show that in addition
toPCK, intracellularMtb requires PPDKas an alternative gateway
into gluconeogenesis. Propionate and cholesterol detoxification
was also identified as an essential function of PPDK revealing an
unexpectedrole for theANAnode inthemetabolismof thesephys-
iologically important intracellular substrates and highlighting this
enzyme as a tuberculosis (TB)-specific drug target. We show that
anaplerotic fixation of CO2 through the ANA node is essential for
intracellular survival ofMtb and thatMtbpossesses three enzymes
(PCA, PCK, and MEZ) capable of fulfilling this function. In addi-
tion to providing a back-up role in anaplerosis we show that MEZ
also has a role in lipid biosynthesis.MEZ knockout strains have an
altered cell wall and were deficient in the initial entry into macro-
phages. This work reveals that the ANA node is a focal point for
controlling the intracellular replicationofMtb,which goes beyond
canonical gluconeogenesis and represents a promising target for
designing novel anti-TB drugs.
Mycobacterium tuberculosis (Mtb)2 is the causative agent
of a global tuberculosis epidemic that has now reached stag-
gering levels and is the biggest infectious disease killer
worldwide (1). The limited number of drugs available that
have activity against Mtb, the lengthy multidrug regimen
needed to eradicate the infection, and the worldwide spread
of multi- and extensively drug-resistant strains (2, 3) all com-
plicate the treatment of tuberculosis (TB) and thwart
attempts to control this global emergency.Mtb is an unusual
bacterial pathogen, with the remarkable ability to cause both
acute life threatening disease and also clinically latent infec-
tions that can persist for the lifetime of the human host.
Metabolic reprogramming in response to the host niche dur-
ing both acute and chronic phases of TB infections is a cru-
cial determinant of virulence (4, 5). Experimental evidence
has identified central carbon metabolism as instrumental in
this pathogenic strategy (4, 6). Therefore an in-depth knowl-
edge and understanding of the central metabolism both in
vitro and in vivo will expedite the identification and valida-
tion of novel strategies to combat TB.
We previously applied the systems-based tool 13C-flux spec-
tral analysis (13C-FSA) to show that intracellular Mtb co-me-
tabolizes multiple gluconeogenic and glycolytic carbon sub-
strates by utilizing the reactions of the phosphoenolpyruvate
(PEP)–pyruvate–oxaloacetate (OAA) or anaplerotic (ANA)
node, in both the gluconeogenic and carbon-fixing anaplerotic
direction simultaneously (7). The ANAnode consists of several
bidirectional reactions, modeling is not able to predict which
genes and reactions are required nor their directionality (8).
TheANAnode lies at the heart of the centralmetabolism inter-
connecting the main pathways of the central metabolism (gly-
colysis, gluconeogenesis, and the TCA cycle) controlling the
distribution of flux between anabolism, catabolism, and energy
supply to the cell (9). At this node the endproducts of glycolysis,
PEP and pyruvate, either: 1) serve directly as precursors for
anabolism or 2) enter the TCA cycle via acetyl Co-A or
anaplerotic reactions and this node is also the starting point
for gluconeogenesis.
The ANA node of Mtb consists of the enzymes pyruvate
carboxylase (PCA), PEP carboxykinase (PCK), malic enzyme
(MEZ), and pyruvate phosphate dikinase (PPDK) (Fig. 1). Of
these enzymes, only PCK has been shown to have an essential
role in gluconeogenesis when Mtb is growing on lipid sub-
strates in vitro and for survival in macrophage and murine
models of TB (4) or hypoxia in a chemostat (10). The role of the
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other members of the ANA node in TB pathogenesis remains
unexplored.
In this study we use a combination of genetics and biochem-
istry to test the redundancy within the ANA node to establish
whether targeting its deregulation could inhibit intracellular
nutrient acquisition and therefore intracellular growth. We
show that in addition to being a gateway into both gluconeo-
genesis and anaplerosis, the ANA node has unexpected roles in
cholesterol and propionate detoxification and lipid synthesis.
Despite apparent functional overlap, we show that each enzyme
of the ANAnode fulfils a distinctmetabolic function during the
intracellular growth ofMtb and is thereby a potentially fruitful
target for drug development.
Results
In silicoGenome ScaleMetabolic Networks (11–13) indicate
that the ANA node of Mtb consists of a set of functionally
redundant enzymes (Fig. 1). Nevertheless, the essential role of
PCKduring gluconeogenesis and intracellular survival (4) dem-
onstrates that at least this enzyme plays a role that cannot be
complemented by other ANA enzymes. To define the role of
each enzyme in the ANA node we generated single mutant
H37Rv strains pca, pck, ppdk, mez and also a double
mutant strain pca–pck. The growth rates of these mutants
were similar to that of theWT strain when cultured in standard
Middlebrook 7H9 with glycerol and Tween 80 demonstrating
that these enzymes are not required for bacterial growth in rich
media (Fig. S1).
The ANA node is required for intracellular invasion and
replication
To test whether the ANA node is important forMtb during
intracellular growthwe infectedTHP-1macrophageswithWT,
pca, pck, ppdk, mez, and pca–pck (Fig. 2A) and their
respective complemented strains (Fig. 2B) of Mtb and moni-
tored intracellular invasion and survival. Deletion of pca had no
observable effect on intracellular bacterial growth (Fig. 2A).
However, surprisingly deletion of both pca and pck resulted
in severe impairment of intracellular survival and loss of the
strain from the macrophage (Fig. 2, A and B). As described
previously for the Erdman strain ofMtb (4) pckH37Rv also
had impaired survival but this phenotype was not as severe in
comparison to pca–pck (Fig. 2, A and B). These results
demonstrated that PCA is essential for intracellular growth
in the absence of PCK.
ppdk had a similar intracellular growth defect to Mtb
strains lacking PCK (Fig. 2A) indicating that this enzyme is also
performing an essential role during infection. Although intra-
cellular mez replicated as the parental strain this mutant was
less efficient at entering macrophages indicating an invasion
phenotype (Fig. 2, C and D).
Anaplerosis through the ANA node is essential for intracellular
growth
To understand the intracellular phenotypes we next investi-
gated the ability of our ANA enzymemutants to grow on phys-
iologically relevant carbon sources. PCA was required for
growth on pyruvate and substrates that enter metabolism as
pyruvate (alanine, serine, and lactate) (Table S1). This pheno-
type could be complemented by reintroducing the gene into the
genome under control of the constitutive hsp60 promoter into
the attB site; but could also be complemented by addition of
aspartate (as proxy for oxaloacetate, which is labile (14) to
the media or by growing the cultures in the presence of 5%
CO2 (Table S1). These results demonstrated that PCA is per-
forming an anaplerotic function replenishing oxaloacetate
(hence aspartate rescues the mutant) into the TCA cycle
when growing on these substrates; but that this role can be
complemented when sufficient CO2 is present presumably
by the actions of either MEZ or PCK. It has already been
shown by us and others that Mtb PCK can operate in the
carboxylating (anaplerotic) direction (15, 16), however, the
role of MEZ is unknown.
PCK was required for the growth of Mtb H37Rv on all
gluconeogenic substrates tested (Tables S1 and S2) including
those identified as potential intracellular carbon sources by
us and others (acetate, glutamate, asparagine, cholesterol,
alanine, and combinations of these substrates and their by-
products) (17). This is in accordance with data for Mtb Erd-
man, which showed that the gluconeogenic flux of acetate
was blocked in the absence of PCK (4). The double pca–
pck mutant grew identically to the pck mutant on the
media tested, except that this strain was additionally unable
to grow on glycerol unless supplemented with 5% CO2
(Table S1) suggesting that, in vitro, MEZ is able to comple-
Figure 1. The PEP–pyruvate–oxaloacetate node or ANA node of
metabolism inMtb. The larger arrows point into the predicted physiolog-
ical direction.
The anaplerotic node ofMtb
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ment the anaplerotic function of PCA if provided with suffi-
cient amounts of CO2.
To directly test the hypothesis that PCA is performing an
anaplerotic function during intracellular growth and that MEZ
functions anaplerotically in the absence of both PCA and PCK
we infected unlabeled THP-1 macrophages with WT H37Rv,
pca, and pca–pck in RPMI medium containing sodium
[13C]bicarbonate/RPMI and compared the labeling profile of
amino acids after 48 h. We previously performed this experi-
ment with pck and showed that this enzyme was contributing
to the intracellular fixation of CO2 (7). In the absence of PCA,
13C incorporation into proteogenic amino acids was signifi-
cantly reduced as compared with theWT strain demonstrating
that this enzyme was also contributing to the fixation of carbon
from CO2 during intracellular growth (Fig. 3, Table S3). The
results are consistent with the in vitro evidence that PCA func-
tions primarily as an anaplerotic enzyme. In the double knock-
out of PCA and PCK 13C labeling of amino acids was further
reduced as compared with pca but there were still small
amounts of 13C labeling in aspartate and methionine demon-
strating that there is an additional enzyme fixing carbon into
OAA, presumablyMEZ (Fig. 3, Table S3). However, this dimin-
ished CO2 fixation correlated with reduced intracellular sur-
vival highlighting the importance of anaplerosis through the
ANA node for infection.
MEZ has a role in lipid biosynthesis
Although mez was dispensable for the growth of Mtb
H37Rv on all gluconeogenic substrates and glycolytic sub-
strates tested (Tables S1 and S2), the mutant displayed a glossy
and viscous morphology on solid media, which combined with
the impaired invasion phenotype suggested that this strainmay
have an altered cell wall lipid profile.
To test whether the altered in vitro growthmorphology phe-
notype was due to alterations in the cell envelope lipid compo-
Figure 2. Invasion and intracellular survival of the ANA mutants in THP-1 macrophages. A–D, intracellular survival of (A) WT, pca, pck, ppdk,
pca–pck, (B) respective complemented strains, (C) mez and (D) uptake of mez in THP-1 macrophages. Data represent the mean of 3–6 independent
experiments; error bars indicate the S.E. NS, not significant; *, p 0.05; **, p 0.01; ***, p 0.001 relative to the WT control.
Figure 3. PCK and PCA are both required for the fixation of carbon from
CO2 when Mtb is growing intracellularly within THP-1 macrophages.
Shown is 13C incorporation into proteogenic amino acids by WT Mtb (blue
bars),pca (red bars), andpca–pck (green bars) after 48 h of growing intra-
cellularly within THP-1 macrophages in the presence of sodium [13C]bicar-
bonate. Error bars indicate S.D. of 3–4 samples from independent macro-
phage infections.
The anaplerotic node ofMtb
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sition, we biochemically analyzed the lipid content of WT,
mez, and the complemented strain mez:mez.We extracted
apolar and polar lipids from the strains and analyzed the
extracts by 2D thin-layer chromatography (TLC). The strains
were initially treated with petroleum ether to extract outer,
non-covalently bound lipids, prior to extraction of inner apolar
lipids and polar lipids. The mez mutant showed an accumula-
tion of a major species in solvent System C (18) that co-mi-
grated in the same region where free fatty acids (FA) and free
mycolic acids (MA) are detected (Fig. 4A, Fig. S2). Subsequently
we extracted mycolic acid methyl esters (MAMEs) from apolar
lipids (containing trehalose mono- and dimycolates, TMM and
TDM, and free FA) and confirmed thatmezwas accumulating
free MA with an accompanying decrease in the levels of cell
wall-boundmycolates fromdelipidated cells (Fig. 4B). This data
were further supported by GC-MS analysis, which detected
higher levels of C26 species in the mez strain (Fig. S3). Lipid
profiles were restored to those of the parental strain on com-
plementation (Fig. 4, Figs. S2 and S3).
Malic enzymes catalyze the reversible oxidative decarboxy-
lation ofmalate to produceCO2 andpyruvatewith the concom-
itant reduction of NAD(P) to NAD(P)H. These enzymes vary
in their reversibility and cofactor preference and their role in
metabolism is often not clearly established. To validate Mtb
MEZ functional properties we determined the catalytic prop-
erties of the purified enzyme (Table 1).
The enzyme was able to decarboxylate malate (forward, glu-
coneogenic, reaction) using either NAD or NADP with a
preference for NAD demonstrating that this enzyme can
provide both NADH and NADPH for lipid biosynthesis. The
enzyme showed a sigmoidicity at low malate concentrations
indicating homotropic allosteric regulation. The reverse reduc-
tive pyruvate carboxylation reaction showed typical Michaelis-
Menten kinetics confirming that Mtb MEZ can serve as a
backup anaplerotic enzyme for Mtb. However, the substrate
affinities and maximum reaction rates show that the forward
reaction is preferred.
PPDK is essential for cholesterol and propionate detoxification
The combined actions of MEZ and PPDK should be able to
provide Mtb with an alternative gluconeogenic route that cir-
cumvents the requirement for PCK (Fig. 1). Strikingly, ppdk
was able to grow on all gluconeogenic and glycolytic substrates
testedwith the exception ofmediumcontaining cholesterol as a
sole carbon source or a combination of cholesterol and acetate,
even though the mutant could grow in acetate as a sole carbon
source (Tables S1 and S2). Moreover, addition of cholesterol to
minimal media containing pyruvate, glycerol, or glutamate
similarly inhibited the growth of ppdk (Table S2). This phe-
notype has been observed in other mutantMtb strains that are
unable to metabolize cholesterol and has been linked to the
accumulation of toxic propionyl-CoA produced from choles-
terol catabolism (19, 20).
Propionate did indeed inhibit the growth ofppdk in stan-
dard 7H9 medium (containing glycerol and Tween 80) as
compared with the WT or the complemented strain ppdk:
Figure 4. Loss ofMEZ leads to the accumulationof freemycolic acids.A, TLC analysis of apolar lipids extracted fromWT,mez, andmez:mez separated by
2D TLC using solvent system C: chloroform/methanol (96:4, v/v) in the first direction and toluene/acetone (80:20, v/v) in the second direction, 5% ethanolic
molybdophosphoric acid, followed by charring. B, TLC analysis of MAMEs derived from apolar lipids and delipidated cells of: 1) WT; 2)mez; and 3)mez:mez.
á, MAMEs;M,methoxy MAMEs; K, keto MAMEs.
The anaplerotic node ofMtb
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ppdk (Fig. 5A) demonstrating that PPDK plays a role in
detoxifying propionyl-CoA. In contrast pck was not intox-
icated by either cholesterol or propionyl-CoA (Table S2, Fig.
5A). In fact deletion of pck enhanced the growth of Mtb in
the presence of propionate as compared with the WT strain
(Fig. 5A).
Mtb has two pathways for metabolizing propionyl-CoA, via
themethyl citrate cycle to yield pyruvate and succinate or in the
presence of sufficient vitamin B12 the methyl malonyl pathway
to yield succinyl-CoA. Activation of the methyl malonyl
pathway with vitamin B12 restored growth of ppdk in pro-
pionate (Fig. 5B) suggesting that PPDK provides a link
between the methyl citrate cycle-derived pyruvate and the
rest of metabolism.
To further explore the intracellular metabolic profile of
this mutant we performed 13C isotopologue experiments with
prelabeled THP-1 macrophages. THP-1 macrophages were
passaged in [13C]glucose/RPMI as previously described (7).
These were infected withWT and ppdk for 48 h. We selected
this time point as the ppdk mutant showed no detectable
growthphenotype at this time so fluxes could be comparedwith
WT (Fig. 2). Also, the labeling profile of amino acids is at an
isotopic steady state by 48 h (7). These data were analyzedman-
ually using the results from our previous flux analysis as a tem-
plate (7). We focused the analysis on amino acids with 13C pro-
files, which were significantly different from theWT to identify
major defects in metabolism consequent to enzyme deletion
(Table S4, Fig. 6).
In the absence of PPDK there was a block in gluconeogenic
flow (Table S4, Fig. 6). 13C enrichment occurred only in amino
acids derived from metabolites occurring below pyruvate but
not in those amino acids derived from glycolytic intermediates
(Fig. 6, Table S4). These data show that during intracellular
growth PPDK provides an alternative to PCK as a gateway into
gluconeogenesis and that both of these routes are required for
the intracellular survival ofMtb.
Discussion
A number of studies highlight the importance of individual
enzymes of glycolysis, gluconeogenesis, and the TCA cycle to
the virulence strategy of Mtb. These pathways are intercon-
nected by four enzymes at ametabolic cross-roads knownas the
ANA node (9). Here we demonstrate that although there is
some functional overlap, each of these enzymes fulfils a unique
metabolic function during intracellular growth. In addition to
its canonical role in gluconeogenesis and anaplerosis we reveal
that the ANA node has unexpected roles in lipid biosynthesis
and detoxifying cholesterol and propionate.
We previously demonstrated that Mtb is able to fix carbon
from CO2 both in vitro (15) and also when growing intracellu-
larly (7). We show here thatMtb has three potential routes for
the replenishment of C4 intermediates catalyzed by PCK, PCA,
or MEZ and that disruption of two of these routes severely
compromises the intracellular survival of Mtb demonstrating
that CO2 fixation plays a fundamental role inMtb’s survival in
its human host cell. At ambient CO2 levels in vitro PCAwas the
dominant anaplerotic enzyme required for growth on pyruvate
but at higher CO2 levels this enzyme was redundant. However,
deletion of both PCA and PCK fromMtb led to severe intracel-
lular growth defects.
Figure 5. PPDK deficiency sensitizesMtb to propionate toxicity, which is rescued by the addition of vitamin B12. A, ppdk growth is inhibited in the
presenceof propionate. Bacterial growthmeasuredby absorbancewasdetermined forWT (solid blue),pck (solid purple),ppdk (solid yellow), andppdk:ppdk
(dashed yellow) grown for 14 days in 7H9mediumcontainingglycerol and 20mM sodiumpropionate. B,propionate toxicity inppdk is rescuedby the addition
of 10 g ml1 of vitamin B12 (VB12). Bacterial growth measured by absorbance was determined after 14 days. Error bars are representative of S.E. of 3–6
independent biological replicates. **, p 0.01; ***, p 0.001 relative to the WT control.
Table 1
Kinetic constants forMtbMEZ
Kinetic values are given as averages S.E.
Substrate (concentration range; pH) Km/K0.5 Vmax Vmax/Km
mM mmol min1 mol1 min1mol1
Gluconeogenic reaction (L-malate decarboxylation)
L-Malate (0.25–100 mM; pH 7.4) with NAD 18.86 0.52a 127.3 1.75 6.75
L-Malate (0.25–100 mM; pH 7.4) with NADP 40.38 0.51a 43.92 0.39 1.09
Anaplerotic reaction (pyruvate carboxylation)
Pyruvate (20–100 mM; pH 7.4) with NADH as cofactor 91.98 6.73 5.17 0.22 0.06
a Kinetics for these reactions are sigmoidal and the reported values are K0.5 values.
The anaplerotic node ofMtb
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PCA enzymes are among the most efficient carboxylating
enzymes, whereas all others includingMEZ and PCKhave poor
activity under ambient CO2 concentrations (21). It was previ-
ously shown by us and others that PCK can also function as a
carboxylase (7, 16). Here, functional analysis ofMtbMEZ con-
firms that this enzyme can also function as a carboxylating
enzyme. However, for MEZ to contribute to TCA cycle replen-
ishment, pyruvate would need to accumulate to high intracel-
lular concentrations and therefore MEZ is likely to play a sub-
ordinate role when alternative anaplerotic routes (PCA and
PCK) are operational. Moreover MEZ was unable to compen-
sate for the loss of both PCA and PCK in the complex intracel-
lular environment.
Malic enzymes have been studied extensively in eukaryotes.
However, the role of this enzyme in pathogenic bacteria is not
well understood. Potential roles include provision of: 1) pyru-
vate during gluconeogenesis; 2) carbon during anaplerosis; and
3) reducing power for fatty acid synthesis (22). We confirmed
that Mtb MEZ can function anaplerotically as a carboxylase
although this enzyme preferentially catalyzes the oxidative
decarboxylation of malate to pyruvate. Deletion ofmez had no
effect on metabolism of glycolytic or gluconeogenic substrates.
However, we detected alterations in the colonial morphology,
cell wall lipid composition, and an intracellular invasion phe-
notype in MEZ-deficient Mtb. Interestingly the excess of free
mycolates detected in the mutant has also been observed in
mycobacterial biofilmswhere it is associatedwith the activity of
an esterase (23). Although this enzyme has a preference for
NAD,MtbMEZ is one of a small number ofmalic enzymes that
have duel cofactor specificity and can therefore produce both
NADH and NADPH as reductants. The dogma is that the de-
hydrogenase reactions of the oxidative pentose phosphate
pathway are the major providers of reducing power in bacteria.
However, the importance of alternative NADPH-generating
Figure 6. Deletion of PPDK disrupts gluconeogenesis of intracellularMtb. Shown is 13C isotopomer incorporation into proteogenic amino acids isolated
from intracellularWTandppdk after 48h infectionof pre-labeled (with [U-13C6]glucose) THP-1macrophages superimposedonametabolic networkof central
metabolism with the positioning of each chart indicating the source of the carbon backbone of each amino acid. Only the amino acids that had significant
changes as compared with WT are displayed. Error bars indicate S.D. of 3 to 4 samples from independent macrophage infections.
The anaplerotic node ofMtb
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reactions has recently become evident (24). Malic enzymes are
associated with a role in controlling lipid metabolism through
the provision ofNADPH in eukaryotes (22) andwe hypothesize
that this is also the case forMtb, which is unusual in requiring
both NADH and NADPH as reductants to fuel its fatty acid
synthase systems, FASI and -II. Malic enzyme may be particu-
larly important when Mtb is dieting on carbon sources, which
have low flux through the pentose phosphate pathway. We are
currently exploring this hypothesis further.
During intracellular growthMtb is reliant on gluconeogene-
sis to metabolize a mixture of substrates including amino acids
(7), fatty acids and cholesterol (17), and mutants lacking genes
involved in gluconeogenesis fail to establish infections in
macrophages andmurinemodels of TB (4, 6). Gluconeogenesis
is essential for the pathogen to make amino acids (serine, histi-
dine, phenylalanine, and tyrosine) in addition to sugars such as
trehalose, which are essential for cell wall biosynthesis aswell as
puridines tomakeDNA and RNA. The inability of the pck dele-
tion mutant to grow in vitro on any gluconeogenic substrate
shown here and by others (4) indicated that PCK cannot be
functionally replaced by PPDK in vitro suggesting that this
enzymewas not operative inMtb (25). Herewe show that this is
not the case and that PPDK is essential for intracellular survival.
Indeed 13C isotopomer analysis demonstrated that this enzyme
is in fact an essential gateway into gluconeogenesis during
intracellular growth. Thiswork further confirms that gluconeo-
genesis is critical for intracellular growth of Mtb and reveals
that PPDK is essential in this process.
The metabolism of host cholesterol has an essential role in
TB infection (17, 26, 27) and therefore cholesterol metabolism
has been highlighted as a drug target (28, 29). Here we have
shown that PPDK has an essential role in the metabolism of
cholesterol. We further demonstrated that strains lacking
PPDK fail to grow if cholesterol is present in the medium. This
form of intoxication has been described for other mutants (20,
26, 30) where it is associated with the inability to assimilate the
cholesterol breakdown product propionyl-CoA and we con-
firmed that this is also the case here.
Propionyl-CoA metabolism is central to the adaptation of
Mtb to growth on cholesterol (26).Mtb has three strategies for
metabolizing propionyl-CoA via: 1) the methyl citrate cycle to
produce pyruvate and succinate; 2) the methyl malonyl path-
way leading to succinyl-CoA production; or 3) incorporation
into cell wall lipids (19). The growth ofppdkwas inhibited by
propionate even in the presence of an alternative carbon
source demonstrating that propionate, or its by-products,
were intoxicating this mutant. Activation of the methyl mal-
onyl pathway with vitamin B12 rescued this phenotype, indi-
cating that PPDK provides a link between the methyl citrate
cycle and the rest of metabolism. Propionyl-CoA toxicity is
not fully understood in bacteria including Mtb but this
metabolite has been shown to be an inhibitor of several
key metabolic enzymes including pyruvate dehydrogenase
(PDH) (31, 32). The end product of the methyl citrate cycle is
pyruvate, which could be channeled through PPDK to circum-
vent the requirement for PDH. Deletion of the alternative glu-
coneogenic route driven by PCK actually mitigates propionyl-
CoA toxicity indicating that PPDK provides a uniquely
essential gluconeogenic route for metabolizing propionyl-
CoA-derived metabolites.
We posit that during intracellular growth when Mtb is co-
metabolizing a mixture of gluconeogenic carbon substrates (6,
7), having two gluconeogenic gateways provides Mtb with a
selective advantage. PPDK provides more efficient recovery of
carbon from substrates that are metabolized via pyruvate such
as propionyl-CoA. Through PCK a minimum of 2 mol of pyru-
vate are required to form 1mol of PEP via PDH and the glyoxy-
late or tricarboxylic acid cycle, whereas the molar ratio is 1:1
using PPDK.However, an additional ATP is necessary to regen-
erate ADP from AMP when using PPDK and therefore PCK
provides an energy efficient route to make sugars from lipids.
Utilizing both routes provides Mtb as an effective strategy to
minimize propionyl-CoA toxicity and maximize ATP produc-
tion. The absence of PPDK orthologues in mammals should
facilitate the development of gluconeogenesis inhibitors as new
drugs for the treatment of tuberculosis.
In summary we show that the ANA node acts as a gateway
into gluconeogenesis and anaplerosis in addition to non-ca-
nonical roles in cholesterol detoxification and lipogenesis and is
essential for the intracellular life cycle ofMtb. Deregulating this
node offers an attractive alternative to conventional antimicro-
bial chemotherapy.
Experimental procedures
Bacterial strains and growth conditions
Escherichia coli strain DH5 was grown in solid or liquid
Luria-Bertani (LB) media. Frozen stocks of Mtb were culti-
vated using Middlebrook 7H11 agar containing 5% (v/v)
oleic acid/albumin/dextrose/catalase (OADC) enrichment
medium supplement (BD) and 0.5% (v/v) glycerol or Middle-
brook 7H9 broth containing 0.2% (v/v) glycerol, 0.2% (v/v)
Tween 80, and 5% (v/v) ADC. When selection was required,
kanamycin at 20 g ml1, hygromycin at 50 g ml1, X-gal
at 50g ml1, and zeomycin at 25g ml1 were added to the
culture medium.
For the sole carbon growth experiments cultures were grown
until late exponential phase (A600  1.0) in complete 7H9,
washed once with PBS, and plated in triplicate onto Roisin’s
minimal agar (33) containing sole carbon sources, duel carbon
sources, and multiple carbon sources. For consistency the car-
bon source(s) were added to attain an equivalent carbon con-
centration of 109 mM with the exception of acetate, which was
added at 12mM as higher amounts were toxic toMtb. Duplicate
plates for each substrate were incubated for up to 12 weeks. To
test for any mutations that may have given false results any
positives after 6 weeks were independently tested at least twice
more.
Growth curves were performed in 7H9 or Roisin’s minimal
media. For the propionyl-CoA toxicity assays strains were
grown in 7H9 media containing 0.2% (v/v) glycerol, 0.2% (v/v)
Tyloxopol, and 5% (v/v) ADC and 20 mM sodium propionate.
Vitamin B12 (10 g ml1) was added when indicated. Cultures
were inoculated with 1% (v/v) of washed late log phase culture
(A600 1.0). Cell growth was monitored daily.
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Genetic manipulation
The ppdk mutant was constructed using the strategy
described by Stewart et al. (34). Approximately 1-kb regions
flanking ppdk were PCR amplified and cloned on either side of
the hygromycin cassette of the suicide vector pG5, which is a
pSMT100 plasmid carrying a kanamycin resistance gene in
addition to the sacB counter-selectable marker. The resulting
plasmid was electroporated into Mtb H37Rv as described pre-
viously (35). Double crossovers were selected for on 7H11 agar
supplemented with kanamycin, hygromycin, and X-gal. The
pca gene was disrupted by single step homologous recombina-
tion using the specialized phage transduction protocol (36).
Themycobacterial recombineeringsystemwasusedfor thecon-
struction of the single pck and the double pca–pck mutants as
described (37). Briefly, the allelic exchange substrateswere con-
structed by PCR amplification of 500 bp corresponding to
regions upstream and downstream of the gene and subse-
quently inserted into pNCMT so that they flank an antibiotic
resistance gene, hygromycin was used as the antibiotic marker
for pck, and zeomycin was used to generate the pca:pck
mutant. The allelic exchange substrates were then electropo-
rated into Mtb strains expressing phage recombinases. To
restore the phenotypes the WT genes were reintroduced into
themutant strains using suicide vectors that insert into the attB
site ofMtb. Using operon prediction software available online,
pckwas predicted not to be in an operon. ppdkwas predicted to
be the first gene in its operon therefore these genes and 500 bp
upstream of the CDS were reintroduced back into Mtb using
the plasmid pMV306. pcawas predicted to bewithin an operon,
and therefore this gene was cloned downstream of the hsp60
promoter and reintroduced into the genome using the suicide
vector pMV361 PCR. Whole genome sequencing was per-
formed to verify the expected genotypes for all mutants.
Expression and purification of recombinantMEZ
MEZ was cloned into pNIC28-BSA4, a vector for inducible
expression of His-tagged MEZ in E. coli using the primers
5	-TACTTCCAATCCATGAGCGACGCCCGCGT and 3	-TAT-
CCACCTTTACTGTTAGTCATATGCCGGGAG to generate
the pNIC_MEZoverexpression plasmid. The pNIC_MEZover-
expression plasmid was confirmed by Sanger sequencing and
transformed into E. coli Tuner cells (Novagen) for overexpres-
sion in Magic MediaTM (ThermoFisher Scientific) containing
50 g ml1 of kanamycin at 37 °C overnight. The supernatant
containing soluble protein was isolated using a nickel affinity-
based His-trap column (GE Healthcare). Unbound protein
was removed by washing with 15 CV of lysis buffer (50 mM
Tris, pH 7.6, 500mMNaCl, 0.1 mM -mercaptoethanol, 5 mM
MgCl2, 0.5 mM CaCl2, 2% glycerol, 0.1% Triton X-100, 25
mM imidazole) before the protein was eluted in 45 mM Tris,
pH 7.6, 50 mMNaCl, 5 mMMgCl2, 0.5 mMCaCl2, 4% glycerol,
0.1% Triton X-100, 250 mM imidazole. The protein was dia-
lyzed against 50 mM Tris, pH 7.6, 100 mMNaCl, 5 mMMgCl2,
0.5 mM CaCl2, 4% glycerol for 4 h at 4 °C, and then stored at
80 °C.
MEZ enzyme activity was measured at 30 °C by spectropho-
tometrically measuring the NAD(P)H formation or utilization
at 340 nm. Assaying in the direction of pyruvate formation the
reaction mixture contained: 100 mM Tris, pH 7.4, 100 mM
malate, 0.5 mMMnCl2, 1.6 mMNAD(P). Each reaction mixture
used to assay for pyruvate reductive carboxylating activity con-
tained 100 mM Tris, pH 6.0, 50 mM pyruvate, 200 mM KHCO3,
0.5 mM MnCl2, and 0.6 mM NAD(P)H.
Cultivation of human THP-1macrophages
The THP-1 human monocytic cell line was obtained from
ATCC TIB-202. Cells were grown in RPMI 1640 medium sup-
plemented with 0.2% glucose, 0.2% sodium bicarbonate, and
10% heat inactivated fetal calf serum (FCS) (Sigma).
Intracellular bacterial growth assays
THP-1 cells were differentiated with 50 nM phorbol 12-my-
ristate 13-acetate for 72 h at 37 °C, 5% CO2, and 95% humidity.
Cells were washed with PBS supplemented with 0.49 mM Mg2
and 0.68 mM Ca2 (PBS) and 1% FCS. Macrophages were
infected with different strains ofMtb at a multiplicity of infec-
tion of 0.1 for 4 h at 37 °C. Extracellular bacteria were removed
by washing twice with warm PBS containing 1% FCS. Intracel-
lular bacteria were quantified by lysing the cells with 0.1% Tri-
ton X-100 at the indicated time points and plating dilutions on
7H11 agar.
13C isotopologue profiling of intracellular Mtb
13C isotopologue profiling was performed as described pre-
viously (15). Briefly labeled or unlabeled THP-1 macrophages
were infected with different strains of Mtb at a multiplicity of
infection of 5. After a 4-h incubation the macrophages were
washed and incubated for 48 h before the mammalian and bac-
terial fractions were separated and used as a probe for the anal-
ysis of 13C labeling of amino acids in host macrophages and
intracellularMtb respectively.
13C biomass hydrolysate and preparation of amino acid
derivatives
Amino acid derivatives were prepared from bacterial and
host cell fractions as previously described (15). These were cor-
rected for the natural abundance of all stable isotopes.
Extraction and analysis of lipids frommycobacterial strains
Extraction of polar, apolar lipids, and MAMEs from the
conditional mutant, and subsequent TLC analysis was car-
ried out using protocols described in Ref. 18. Dry weights of
cell pellets were used as a measure to equalize loading on
TLC plates using solvent systems A–D for apolar lipids and
systems D and E for polar lipids. The GC-free induction
decay analysis of FAMEs was performed on a Shimadzu
GC-2010. The FAMEs separation was achieved using a
DB-225 column (30 m 
 0.25-mm inner diameter, 0.25 m
film thickness, J&W Scientific) with a column flow of 1.26
ml/min (helium at a constant pressure of 100 kilopascal).
Injector and detector temperatures were 50 °C. The injec-
tion volume was 5 l. The column temperature was pro-
grammed initially at 50 °C for 2 min, increased at the rate of
4 °C/min to 220 °C, and then maintained at 220 °C for a fur-
ther 30.5 min. The total program time was 75 min.
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Table S1. Sole carbon sources utilised by wild type and mutant strains of Mycobacterium 
tuberculosis 
  Strain 
Carbon 
source 
WT ∆mez ∆pca ∆pca:
pca 
∆pck ∆pck:
pck 
∆ppdk ∆ppdk:
ppdk 
∆pca
-
∆pck 
∆pca 
∆pck:pck 
∆pca 
∆pck:pca 
Ala (O2) + + NG ++ NG +++ ++ +++ NG NG NG 
Ala (CO2) ++ NT ++ ++ NG +++ +++ +++ NG +++ NG 
Ace (O2) +++ +++ + NT NG +++ +++ NT NG +++ NG 
Ace (CO2) +++ NT ++ NT NG +++ +++ +++ NG +++ NG 
Chol (O2) +++ +++ + NT NG ++ NG +++ NG +++ NG 
Chol (CO2) +++ NT + NT NG ++ NG +++ NG +++ NG 
Gluc (O2) + + + NT + NT + NT + NT NT 
Gluc (CO2) + NT + NT + NT ++ NT + NT NT 
Glyc (O2) ++ ++ ++ ++ ++ ++ + NT NG NG ++ 
Glyc (CO2) + NT + ++ +++ ++ ++ ++ +++ +++ +++ 
Glu (O2) + + + NT NG + + + NG + NG 
Glu (CO2) + NT + NT NG + + + NG + NG 
Pyr (O2) ++ ++ NG + NG ++ ++ ++ NG NG NG 
Pyr (CO2) ++ NT + + NG ++ ++ ++ NG +++ NG 
Ser (O2) + + NG + NG + ++ ++ NG NG NG 
Ser (CO2) + NT + NT NG ++ ++ + + + NG 
Succ (O2) ++ ++ + NT NG +++ +++ +++ NG +++ NG 
Succ (CO2) ++ NT + NT NG +++ +++ +++ NG +++ NG 
Ala: alanine; Ace: acetate; Chol: cholesterol; Gluc; glucose; Glyc: glycerol; Glu: glutamate; Pyr: pyruvate; Ser: serine; Succ: 
succinate; O2: ambient air; CO2: 5 % CO2; NG: no growth; NT: not tested; Growth of 20 µl spots from: +: neat; ++: 10-1; 
+++: 10-2 dilutions. 
 
 
 
 
 
 
 
  S-2 
Table S2. Multiple carbon sources utilised by wild type and mutant strains of 
Mycobacterium tuberculosis, related to Fig. 5 
Carbon sources WT ∆mez ∆pca ∆pca:
pca 
∆pck ∆pck:
pck 
∆ppdk ∆ppdk:
ppdk 
∆pca 
∆pck 
∆pca 
∆pck:
pck 
∆pca 
∆pck:
pca 
Ala/Asp 
(O2) 
+ + + NT NG + + NT NG + NT 
Ala/Asp (CO2) + NT + NT NG + NT NT NG + NT 
Ace/chol (O2) +++ +++ NT NT NG +++ NG +++ NG +++ NT 
Ace/chol (CO2) +++ NT NT NT NG ++ NG +++ NG +++ NT 
Pyr/chol (O2) ++ ++ NT NT NG ++ NG +++ NG NG NG 
Pyr/chol (CO2) ++ NT NT NT NG ++ NG +++ NG ++ ++ 
Glyc/chol (O2) + + NT NT + + NG + ++ + ++ 
Glyc/chol (CO2) + NT NT NT + + NG + ++ + ++ 
Glu/chol (O2) ++ ++ NT NT NG ++ NG ++ NG ++ NG 
Glu/chol (CO2) + NT NT NT NG ++ NG + NG + NG 
Ace/pyr (O2) +++ +++ +++ +++ NG ++ ++ +++ NG +++ NT 
Ace/pyr (CO2) +++ NT +++ +++ NG +++ +++ +++ NG +++ NT 
Pyr/Asp (O2) + + + NT NG ++ + NT NG ++ NT 
Pyr/Asp (CO2) + NT + NT NG ++ + NT NG ++ NT 
Succ/Pyr (O2) ++ ++ +++ +++ NG ++ ++ ++ NG ++ NT 
Succ/Pyr (CO2) ++ NT +++ ++ NG ++ + ++ NG +++ NT 
Glu/ala/ser/asp 
(O2) 
++ ++ ++ ++ NG ++ ++ ++ NG +++ NT 
Glu/ala/ser/asp 
(CO2) 
++ NT ++ ++ NG ++ ++ ++ NG +++ NT 
Ace/Asp/Glu/Ala
/pyr (O2) 
++ ++ ++ ++ NG ++ ++ ++ NG ++ NT 
Ace/Asp/Glu/Ala
/pyr (CO2) 
++ NT +++ ++ NG ++++ +++ +++ NG +++ NT 
Ala: alanine; Ace: acetate; Asp: aspartate; Chol: cholesterol; Glyc: glycerol; Glu: glutamate; Pyr: pyruvate; Ser: 
serine; Succ: succinate; O2: ambient air; CO2: 5 % CO2; NG: no growth; NT: not tested; Growth on 20 µl spots from: 
+: neat; ++: 10-1; +++: 10-2 dilutions. 
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Table S3. Total 13C (%) incorporation of proteogenic amino acid derivatives of 
intracellular Mtb, ∆pca and ∆pca ∆pck cultivated with sodium [13C]bicarbonate  
 
WT H37Rv ∆pca  ∆pca ∆pck 
AA Average 
(%) 
Stdev Average 
(%) 
Stdev Average 
(%) 
Stdev 
Ala 1.68 0.26 0.28 0.16 0.10 0.11 
Gly 3.86 0.63 1.25 0.11 0.64 0.86 
Val 1.37 0.15 0.08 0.12 0.00 0.00 
Leu 0.16 0.26 0.00 0.00 0.00 0.00 
Threo 7.46 1.60 1.84 0.08 0.20 0.17 
Asp 7.57 0.65 3.32 0.39 2.42 1.21 
Met 5.69 1.88 1.39 0.27 0.88 0.45 
Phe 2.65 1.44 0.26 0.36 0.00 0.00 
His 2.74 1.10 0.61 0.03 0.00 0.00 
Tyr 5.00 0.94 0.95 1.34 0.01 0.02 
 
  
 
 
 
 
  S-4 
 
Table S4. Experimental (GC-MS) mass distributions in the 
amino acid derivatives of  intracellular wild type H37Rv 
Mtb and Δppdk 
  
WT Mtb H37Rv ∆ppdk 
AA Analyte (m/z) Average Stdev Average Stdev 
Ala260 M+0 84.91 5.12 78.97 1.70 
 
M+1 2.81 0.46 0.98 0.13 
 
M+2 1.92 0.38 1.57 0.12 
 
M+3 10.35 5.33 18.48 1.54 
Gly246 M+0 94.19 1.18 97.18 0.11 
 
M+1 1.81 0.75 0.00 0.00 
 
M+2 4.00 1.21 2.82 0.11 
Val288 M+0 92.49 1.40 98.76 0.17 
 
M+1 4.78 1.26 0.40 0.20 
 
M+2 1.81 0.35 0.39 0.13 
 
M+3 0.85 0.21 0.26 0.05 
 
M+4 0.15 0.03 0.17 0.07 
 
M+5 <LOQ <LOQ 0.02 0.01 
Leu302 M+0 94.71 1.73 97.64 1.54 
 
M+1 2.07 0.69 2.33 1.42 
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M+2 2.51 0.86 0.42 0.27 
 
M+3 0.44 0.25 0.25 0.23 
 
M+4 0.26 0.11 0.01 0.01 
 
M+5 0.05 0.03 0.00 0.00 
 
M+6 <LOQ <LOQ 0.05 0.03 
Ser390 M+0 86.27 2.54 97.83 0.56 
 
M+1 3.97 1.33 0.00 0.00 
 
M+2 2.49 0.72 0.00 0.00 
 
M+3 7.27 4.60 2.17 0.56 
Asp418 M+0 84.45 2.53 84.71 0.34 
 
M+1 4.79 0.44 3.14 0.06 
 
M+2 6.98 1.04 6.95 0.27 
 
M+3 2.65 1.18 3.64 0.15 
 
M+4 1.14 0.61 1.56 0.07 
Glu432 M+0 84.28 2.89 81.66 2.67 
 
M+1 4.35 1.12 4.52 0.66 
 
M+2 7.15 1.24 6.45 3.81 
 
M+3 1.94 0.57 3.38 0.81 
 
M+4 1.50 0.76 2.89 0.51 
 
M+5 0.77 0.44 1.11 0.51 
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Phe336 M+0 92.08 3.03 98.97 0.32 
 
M+1 3.70 1.96 0.00 0.00 
 
M+2 2.46 0.92 0.11 0.14 
 
M+3 1.25 0.54 0.17 0.05 
 
M+4 0.69 0.30 0.15 0.10 
 
M+5 <LOQ <LOQ 0.08 0.01 
 
M+6 <LOQ <LOQ 0.19 0.13 
 
M+7 <LOQ <LOQ 0.10 0.03 
 
M+8 <LOQ <LOQ 0.29 0.28 
 
M+9 <LOQ <LOQ 0.09 0.07 
His440 M+0 86.81 5.09 97.86 0.09 
 
M+1 7.42 3.26 0.05 0.08 
 
M+2 3.39 1.20 0.47 0.16 
 
M+3 1.80 0.64 0.98 0.13 
 
M+4 0.44 0.20 0.28 0.11 
 
M+5 0.19 0.17 0.30 0.09 
 
M+6 <LOQ 
 
0.05 0.04 
Tyr376 M+0 83.16 6.54 95.95 0.52 
 
M+1 9.18 4.38 0.14 0.12 
 
M+2 4.08 1.65 0.44 0.08 
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M+3 2.20 1.15 1.51 0.13 
 
M+4 1.07 0.69 0.23 0.10 
 
M+5 0.41 0.18 0.32 0.14 
 
M+6 <LOQ <LOQ 0.63 0.20 
 
M+7 <LOQ <LOQ 0.40 0.42 
 
M+8 <LOQ <LOQ 0.23 0.12 
 
M+9 <LOQ <LOQ 0.20 0.06 
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Figure S1. Deleting genes of the ANA node has no impact on growth in standard 
Middlebrook 7H9 medium 
Growth (OD600) of WT (blue), Δpca (red), Δpck (purple), Δppdk (yellow), Δmez 
(grey) Δpca-Δpck (green) strains of Mtb in 7H9 media. The mean OD600 ± SEM of 
triplicate independent cultures is given. 
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Figure S2. 2D-TLC Analysis 
Analysis of petroleum ether extracts, and subsequently extracted apolar and polar 
lipids from WT, Δmez and Δmez: mez. Solvent systems A-E are as described by 
Dobson et al (1985). 
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Figure S3. GC-MS analysis of fatty acyl methyl esters prepared from apolar 
lipids shows an increase of a C26 lipid species at 54.5 in Δmez 
GC-MS of WT (A), Δmez (B) and complemented Δmez: mez strains of Mtb.  Sigma-
Aldrich fatty acyl methyl esters were used as standards. 
